Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Sulfurovum sp. Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP411514SUZ
CSB-EP411514SUZ
CSB-BP411514SUZ
CSB-MP411514SUZ
CSB-EP411514SUZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfurovum sp. 1- (5-phosphoribosyl)-5-[ (5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase CSB-YP411515SUZ
CSB-EP411515SUZ
CSB-BP411515SUZ
CSB-MP411515SUZ
CSB-EP411515SUZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfurovum sp. UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC) CSB-YP411516SUZ
CSB-EP411516SUZ
CSB-BP411516SUZ
CSB-MP411516SUZ
CSB-EP411516SUZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfurovum sp. Peptidyl-tRNA hydrolase (pth) CSB-YP411517SUZ
CSB-EP411517SUZ
CSB-BP411517SUZ
CSB-MP411517SUZ
CSB-EP411517SUZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfurovum sp. N- (5'-phosphoribosyl)anthranilate isomerase CSB-YP411518SUZ
CSB-EP411518SUZ
CSB-BP411518SUZ
CSB-MP411518SUZ
CSB-EP411518SUZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfurovum sp. Sec-independent protein translocase protein TatA (tatA), partial CSB-YP411519SUZ
CSB-EP411519SUZ
CSB-BP411519SUZ
CSB-MP411519SUZ
CSB-EP411519SUZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfurovum sp. Ribonuclease H (rnhA) CSB-YP411520SUZ
CSB-EP411520SUZ
CSB-BP411520SUZ
CSB-MP411520SUZ
CSB-EP411520SUZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfurovum sp. 30S ribosomal protein S19 (rpsS) CSB-YP411521SUZ
CSB-EP411521SUZ
CSB-BP411521SUZ
CSB-MP411521SUZ
CSB-EP411521SUZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfurovum sp. 30S ribosomal protein S14 type Z (rpsZ) CSB-YP411522SUZ
CSB-EP411522SUZ
CSB-BP411522SUZ
CSB-MP411522SUZ
CSB-EP411522SUZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfurovum sp. 30S ribosomal protein S13 (rpsM) CSB-YP411523SUZ
CSB-EP411523SUZ
CSB-BP411523SUZ
CSB-MP411523SUZ
CSB-EP411523SUZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfurovum sp. Ribosomal RNA large subunit methyltransferase N (rlmN) CSB-YP411524SUZ
CSB-EP411524SUZ
CSB-BP411524SUZ
CSB-MP411524SUZ
CSB-EP411524SUZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Serine--tRNA ligase (serS) CSB-YP411525FLG
CSB-EP411525FLG
CSB-BP411525FLG
CSB-MP411525FLG
CSB-EP411525FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP411526FLG
CSB-EP411526FLG
CSB-BP411526FLG
CSB-MP411526FLG
CSB-EP411526FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Antiholin-like protein LrgA (lrgA), partial CSB-YP411527FLG1
CSB-EP411527FLG1
CSB-BP411527FLG1
CSB-MP411527FLG1
CSB-EP411527FLG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 30S ribosomal protein S18 (rpsR) CSB-YP411528FLG
CSB-EP411528FLG
CSB-BP411528FLG
CSB-MP411528FLG
CSB-EP411528FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP411529FLG
CSB-EP411529FLG
CSB-BP411529FLG
CSB-MP411529FLG
CSB-EP411529FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 50S ribosomal protein L1 (rplA) CSB-YP411530FLG
CSB-EP411530FLG
CSB-BP411530FLG
CSB-MP411530FLG
CSB-EP411530FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Transcriptional regulator sarA (sarA) CSB-YP411531FLG
CSB-EP411531FLG
CSB-BP411531FLG
CSB-MP411531FLG
CSB-EP411531FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Sensor histidine kinase graS (graS), partial CSB-YP411532FLG1
CSB-EP411532FLG1
CSB-BP411532FLG1
CSB-MP411532FLG1
CSB-EP411532FLG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus UDP-N-acetylenolpyruvoylglucosamine reductase (murB) CSB-YP411533FLG
CSB-EP411533FLG
CSB-BP411533FLG
CSB-MP411533FLG
CSB-EP411533FLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>